Published in Strahlenther Onkol on August 01, 2008
Hodgkin lymphoma. J Clin Invest (2012) 1.41
The concept and evolution of involved site radiation therapy for lymphoma. Int J Clin Oncol (2015) 1.40
New ultrasound techniques for lymph node evaluation. World J Gastroenterol (2013) 1.12
State of the art in the treatment of Hodgkin lymphoma. Nat Rev Clin Oncol (2012) 0.95
The use of FDG-PET to target tumors by radiotherapy. Strahlenther Onkol (2010) 0.93
Total body irradiation (TBI) in pediatric patients. A single-center experience after 30 years of low-dose rate irradiation. Strahlenther Onkol (2010) 0.87
Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastases. Strahlenther Onkol (2012) 0.85
Radiotherapy of splenomegaly : a palliative treatment option for a benign phenomenon in malignant diseases. Strahlenther Onkol (2011) 0.82
Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin's disease: a multi-institutional experience. Strahlenther Onkol (2011) 0.79
[Technical and methodical developments of radiation oncology from a physician's point of view]. Strahlenther Onkol (2012) 0.77
Feasibility and toxicity of concomitant radio/immunotherapy with MabThera (Rituximab®) for patients with non-Hodkin's Lymphoma: results of a prospective phase I/II study. Strahlenther Onkol (2011) 0.77
Contribution of three-dimensional conformal intensity-modulated radiation therapy for women affected by bulky stage II supradiaphragmatic Hodgkin disease. Radiat Oncol (2013) 0.77
Clinical relevance of different dose calculation strategies for mediastinal IMRT in Hodgkin's disease. Strahlenther Onkol (2012) 0.77
ISRT: a new radiation therapy for malignant lymphomas : Introduction to the review article by Specht and Yahalom. Int J Clin Oncol (2015) 0.75
Tailored strategies for radiation therapy in classical Hodgkin's lymphoma. Crit Rev Oncol Hematol (2012) 0.75
The impact of protocol assignment for older adolescents with hodgkin lymphoma. Front Oncol (2014) 0.75
Radiation-induced second malignancies after involved-node radiotherapy with deep-inspiration breath-hold technique for early stage Hodgkin Lymphoma: a dosimetric study. Radiat Oncol (2014) 0.75
Conceptus dose from involved-field radiotherapy for Hodgkin's lymphoma on a linear accelerator equipped with MLCs. Strahlenther Onkol (2009) 0.75
The German evidence-based guidelines for Hodgkin's lymphoma. Aspects for radiation oncologists. Strahlenther Onkol (2013) 0.75
Patterns of failure of diffuse large B‑cell lymphoma patients after involved-site radiotherapy. Strahlenther Onkol (2017) 0.75
[Risk of heart failure in patients with Hodgkin lymphoma after radiation and anthracycline chemotherapy]. Strahlenther Onkol (2017) 0.75
Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med (2004) 25.68
Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol (2009) 4.38
Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. N Engl J Med (2010) 2.97
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. Eur Urol (2007) 2.21
Strong adverse prognostic impact of hyperglycemic episodes during adjuvant chemoradiotherapy of glioblastoma multiforme. Strahlenther Onkol (2014) 2.12
Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. Ann Surg Oncol (2007) 2.10
Noninvasive detection of lung cancer by analysis of exhaled breath. BMC Cancer (2009) 1.99
Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group. J Clin Oncol (2007) 1.94
Testicular dose and hormonal changes after radiotherapy of rectal cancer. Radiother Oncol (2005) 1.83
Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys (2003) 1.70
Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry. Clin Chem Lab Med (2009) 1.64
Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys (2003) 1.57
Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous carcinoma of the head and neck. Int J Radiat Oncol Biol Phys (2005) 1.57
Radiation protection in diagnostic radiology. Dtsch Arztebl Int (2008) 1.56
Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur J Radiol (2003) 1.52
Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging. Strahlenther Onkol (2003) 1.51
Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial. J Clin Oncol (2010) 1.46
Effectiveness of radiochemotherapy on lymph node metastases in patients with stage IV oropharyngeal cancer. Oral Oncol (2004) 1.42
How to successfully implement E-learning for both students and teachers. Acad Radiol (2006) 1.41
[The effectiveness of radiation treatment in comparison with extracorporeal shockwave therapy (ESWT) in supraspinatus tendon syndrome]. Strahlenther Onkol (2002) 1.40
Predictive value of carbohydrate antigen 19-9 in pancreatic cancer treated with radiochemotherapy. Int J Radiat Oncol Biol Phys (2003) 1.39
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. Eur Urol (2007) 1.37
Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy? Strahlenther Onkol (2009) 1.33
Metastasis: the seed and soil theory gains identity. Cancer Metastasis Rev (2007) 1.33
Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial. J Clin Oncol (2007) 1.26
The bronchiolar epithelium as a prominent source of pro-inflammatory cytokines after lung irradiation. Int J Radiat Oncol Biol Phys (2005) 1.24
Determination of cell survival after irradiation via clonogenic assay versus multiple MTT Assay--a comparative study. Radiat Oncol (2012) 1.20
(68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate? Eur J Nucl Med Mol Imaging (2015) 1.18
Late effects of thoracic irradiation in children. Strahlenther Onkol (2008) 1.15
Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis. Strahlenther Onkol (2004) 1.14
Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancer. BMC Cancer (2009) 1.14
Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys (2006) 1.13
Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients. Oncol Rep (2008) 1.11
Irradiation induces a biphasic expression of pro-inflammatory cytokines in the lung. Strahlenther Onkol (2004) 1.10
Ion beam radiobiology and cancer: time to update ourselves. Biochim Biophys Acta (2009) 1.09
Radiotherapy for stages IIA/B testicular seminoma: final report of a prospective multicenter clinical trial. J Clin Oncol (2003) 1.08
Radiotherapy for symptomatic vertebral hemangiomas: results of a multicenter study and literature review. Int J Radiat Oncol Biol Phys (2009) 1.07
Intraoperative radiotherapy as accelerated partial breast irradiation for early breast cancer : beware of one-stop shops? Strahlenther Onkol (2010) 1.06
Ovarian function following pelvic irradiation in prepubertal and pubertal girls and young adult women. Strahlenther Onkol (2005) 1.05
Whole lung irradiation in patients with exclusively pulmonary metastases of Ewing tumors. Toxicity analysis and treatment results of the EICESS-92 trial. Strahlenther Onkol (2008) 1.04
Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells. Proteomics (2008) 1.03
The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy. Anticancer Res (2005) 1.02
Late effects of abdominal irradiation in children: a review of the literature. Anticancer Res (2010) 1.02
Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse. Radiother Oncol (2010) 0.99
Providing psychosocial support for breast cancer patients based on screening for distress within a consultation-liaison service. Psychooncology (2004) 0.99
German register for detection of late sequelae after radiotherapy for children and adolescents (RiSK): present status and first results. Strahlenther Onkol (2007) 0.99
Pretreatment with rituximab enhances radiosensitivity of non-Hodgkin's lymphoma cells. J Radiat Res (2005) 0.99
Epidemiological aspects of hadron therapy: a prospective nationwide study of the Austrian project MedAustron and the Austrian Society of Radiooncology (OEGRO). Radiother Oncol (2004) 0.98
Late structural alterations of cerebral white matter in long-term survivors of childhood leukemia. J Magn Reson Imaging (2008) 0.98
Increased expression of pro-inflammatory cytokines as a cause of lung toxicity after combined treatment with gemcitabine and thoracic irradiation. Radiother Oncol (2004) 0.98
Quality control of involved field radiotherapy in patients with early-favorable (HD10) and early-unfavorable (HD11) Hodgkin's lymphoma: an analysis of the German Hodgkin Study Group. Int J Radiat Oncol Biol Phys (2008) 0.98
Decreased high-energy phosphate ratios in the myocardium of men with diabetes mellitus type I. J Cardiovasc Magn Reson (2002) 0.98
Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group. J Clin Oncol (2005) 0.96
Radiotherapy in Ewing tumors of the vertebrae: treatment results and local relapse analysis of the CESS 81/86 and EICESS 92 trials. Int J Radiat Oncol Biol Phys (2005) 0.96
Evaluation of different biomarkers to predict individual radiosensitivity in an inter-laboratory comparison--lessons for future studies. PLoS One (2012) 0.96
Radiation therapy in the multimodal treatment approach of pituitary adenoma. Strahlenther Onkol (2002) 0.96
Neoadjuvant radiochemotherapy and surgery for advanced rectal cancer : prognostic significance of tumor regression. Strahlenther Onkol (2011) 0.95
Increase of hepcidin plasma and urine levels is associated with acute proctitis and changes in hemoglobin levels in primary radiotherapy for prostate cancer. J Cancer Res Clin Oncol (2006) 0.95
Radiotherapy equipment and departments in the European countries: final results from the ESTRO-HERO survey. Radiother Oncol (2014) 0.95
Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients. Strahlenther Onkol (2008) 0.94
Combined-modality treatment in advanced oral squamous cell carcinoma: Primary surgery followed by adjuvant concomitant radiochemotherapy. Strahlenther Onkol (2011) 0.93
Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis. Strahlenther Onkol (2005) 0.93
Ewing's sarcoma and peripheral primitive neuroectodermal tumor cells produce large quantities of bioactive tumor necrosis factor-alpha (TNF-alpha) after radiation exposure. Int J Radiat Oncol Biol Phys (2003) 0.93
Lymphocyte-predominant and classical Hodgkin's lymphoma--comparison of outcomes. Eur J Haematol Suppl (2005) 0.92
Assessment of tumor microcirculation with dynamic contrast-enhanced MRI in patients with esophageal cancer: initial experience. J Magn Reson Imaging (2008) 0.92
Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation. Int J Radiat Oncol Biol Phys (2011) 0.91
Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment? Strahlenther Onkol (2005) 0.91
Randomized study of postoperative radiotherapy and simultaneous temozolomide without adjuvant chemotherapy for glioblastoma. Strahlenther Onkol (2008) 0.91
Long-term results of radiotherapy in primary carcinoma of the vagina. Strahlenther Onkol (2009) 0.90
Identification of genes responsive to gamma radiation in rat hepatocytes and rat liver by cDNA array gene expression analysis. Radiat Res (2006) 0.90
Association of telomerase activity with radio- and chemosensitivity of neuroblastomas. Radiat Oncol (2010) 0.90
Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma. Strahlenther Onkol (2003) 0.90
Role of hematotoxicity and sex in patients with Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group. J Clin Oncol (2005) 0.90
Atlas-based semiautomatic target volume definition (CTV) for head-and-neck tumors. Int J Radiat Oncol Biol Phys (2010) 0.90
Initiation of a teleradiotherapeutic network for patients in German lymphoma studies. Int J Radiat Oncol Biol Phys (2004) 0.90
MPC-6827: a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps. Cancer Res (2007) 0.90
Particle therapy for noncancer diseases. Med Phys (2012) 0.89
Increased expression of EphA7 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients. BMC Cancer (2008) 0.89
Radiotherapy for brain metastases from renal cell cancer: should whole-brain radiotherapy be added to stereotactic radiosurgery?: analysis of 88 patients. Strahlenther Onkol (2010) 0.89
Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial. BMC Cancer (2012) 0.89
Efficacy and toxicity of postoperative temozolomide radiochemotherapy in malignant glioma. Strahlenther Onkol (2005) 0.89
Intraoperative radiotherapy of soft tissue sarcoma of the extremity. Strahlenther Onkol (2004) 0.88
Rectal cancer: assessment of response to neoadjuvant chemoradiation by dynamic contrast-enhanced MRI. J Magn Reson Imaging (2012) 0.88
[Therapy-associated late effects after irradiation of malignant diseases in childhood and adolescence. Feasibility analyses of a prospective multicenter register study]. Strahlenther Onkol (2006) 0.88